Angle first-half loss widens, crucial FDA decision expected this year Read More
IN BRIEF: Angle notes studies supporting Parsortix system in cancer Read More
UK earnings, trading statements calendar - next 7 days Read More
IN BRIEF: Angle's Parsortix used in Spanish study to find cancer Read More
IN BRIEF: Angle's Parsortix enables gene analysis in cancer study Read More
TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million Read More
TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident Read More
IN BRIEF: Angle's Parsortix successfully used to harvest cancer cells Read More
IN BRIEF: Angle raises GBP20.0 million to fund FDA approval drive Read More
IN BRIEF: Angle to raise GBP20 million through shares placing Read More
UK shareholder meetings calendar - next 7 days Read More
TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit Read More
IN BRIEF: Angle responds to additional information request from US FDA Read More
TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets Read More
TRADING UPDATES: Gamma tips 2021 revenue jump; Smart Metering progress Read More
IN BRIEF: Angle's Parsortix system gets Italian research boost Read More
Angle reports wider loss, awaits FDA decision on cancer test equipment Read More
IN BRIEF: Angle enrolls 200 patients for ovarian cancer test study Read More
TRADING UPDATES: AFC raises GBP36 million; Angle wins service contract Read More
